Search
Without access to treatment, can we truly innovate in rare diseases?
Interview with Giampaolo Merlini
There have been many developments on rare diseases since the EU Orphan Medicinal Products Regulation came into force in 2000. As the European Commission is evaluating its effectiveness, EHA discussed with Prof.
Scientific Meetings
The EHA-SWG Scientific Meetings have been developed as a joint effort of the EHA Specialized Working Groups (SWGs) and EHA to intensify the beneficial collaboration.
Read more